Precision Biosciences (DTIL) FCF Margin Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 6,066.00 |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - | 25,399.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,399.00 |
| Dec 31, 2025 | 17,912.00 |
| Sep 30, 2025 | -11.78 Mn |
| Jun 30, 2025 | -11.20 Mn |
| Mar 31, 2025 | -6.50 Mn |
| Dec 31, 2024 | -254,626.00 |
| Sep 30, 2024 | -93,066.00 |
| Jun 30, 2024 | 1,815.00 |
| Mar 31, 2024 | -51,792.00 |
| Dec 31, 2023 | 4,515.00 |
| Sep 30, 2023 | 13,708.00 |
| Jun 30, 2023 | 244,676.00 |
| Mar 31, 2023 | 2,172.00 |
| Dec 31, 2022 | 18,789.00 |
| Sep 30, 2022 | 79,053.00 |
| Jun 30, 2022 | -19,597.00 |
| Mar 31, 2022 | -43,758.00 |
| Dec 31, 2021 | 6,388.00 |
| Sep 30, 2021 | 59,435.00 |
| Jun 30, 2021 | 54,068.00 |